Trial Profile
Prevention of rheumatoid arthritis by atorvastatin in seropositive arthralgia patients: a multi-center doubleblind randomized placebo-controlled trial
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 13 Jan 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms STAPRA
- 28 Jun 2020 Status changed from recruiting to discontinued.
- 25 Apr 2015 Primary drug has been changed from Rosuvastatin to Atorvastatin.
- 25 Apr 2015 Planned number of patients changed from 200 to 220, according to European Clinical Trials Database record.